BIOEQUIVALENCE OF FIXED-DOSE COMBINATIONS OF DAPAGLIFLOZIN/METFORMIN RELATIVE TO SINGLE COMPONENTS IN HEALTHY SUBJECTS

被引：0
|
作者：
Boulton, D. W. [1 ]
Chang, M. [1 ]
Griffen, S. C. [2 ]
Kitaura, C. [1 ]
Lubin, S. [1 ]
Pollack, A. [1 ]
LaCreta, F. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] JDRF, New York, NY USA
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.283
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E98 / E99
页数：2
相关论文
共 50 条
  • [21] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects
    Gummesson, Anders
    Li, Haiyan
    Gillen, Michael
    Xu, John
    Niazi, Mohammad
    Hirshberg, Boaz
    CLINICAL DRUG INVESTIGATION, 2014, 34 (11) : 763 - 772
  • [22] Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects
    Khomitskaya, Yunona
    Tikhonova, Nadezhda
    Gudkov, Konstantin
    Erofeeva, Svetlana
    Holmes, Victoria
    Dayton, Brian
    Davies, Nigel
    Boulton, David W.
    Tang, Weifeng
    CLINICAL THERAPEUTICS, 2018, 40 (04) : 550 - 561
  • [23] Relative bioavailability of isoniazid in a fixed-dose combination product in healthy Mexican subjects
    Milan-Segovia, R. C.
    Vigna-Perez, M.
    Romero-Mendez, M. C.
    Medellin-Garibay, S. E.
    Vargas-Morales, J. M.
    Magana-Aquino, M.
    Romano-Moreno, S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (01) : 49 - 54
  • [24] A RELATIVE BIOAVAILABILITY STUDY OF THE GRAZOPREVIR/ELBASVIR FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS
    Davit, B. M.
    Alon, A.
    Caro, L.
    Feng, H.
    Guo, Z.
    Kesisoglou, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S66 - S67
  • [25] AN ASSESSMENT OF THE PHARMACOKINETICS OF A LOBEGLITAZONE/METFORMIN FIXED-DOSE COMBINATION TABLET IN HEALTHY SUBJECTS.
    Kim, S-Y
    Jeon, J-Y
    Lee, S.
    Park, S-J
    Kim, M-G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S69 - S70
  • [26] Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and coadministration of sitagliptin and metformin.
    Miller, J.
    Migoya, E. M.
    Gutierrez, M.
    Zheng, W.
    Johnson-Levonas, A. O.
    Wagner, J. A.
    Gottesdiener, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S58 - S58
  • [27] Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention
    Seabloom, Donna E.
    Galbraith, Arthur R.
    Haynes, Anna M.
    Antonides, Jennifer D.
    Wuertz, Beverly R.
    Miller, Wendy A.
    Miller, Kimberly A.
    Steele, Vernon E.
    Miller, Mark Steven
    Clapper, Margie L.
    O'Sullivan, M. Gerard
    Ondrey, Frank G.
    CANCER PREVENTION RESEARCH, 2017, 10 (02) : 116 - 123
  • [28] Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis
    Velasquez, Gustavo E.
    Davies, Geraint R.
    Mitnick, Carole D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (05) : 473 - 474
  • [29] Fixed-dose single tablet antidiabetic combinations
    Bailey, C. J.
    Day, C.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 527 - 533
  • [30] Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects A Randomized, Open-Label, Crossover Study
    Migoya, Elizabeth M.
    Miller, Jutta L.
    Gutierrez, Maria
    Zheng, Wei
    Johnson-Levonas, Amy O.
    Liu, Qi
    Matthews, Catherine Z.
    Wagner, John A.
    Gottesdiener, Keith M.
    CLINICAL DRUG INVESTIGATION, 2010, 30 (12) : 855 - 866
12345